Anthony P. Mack - Jan 31, 2022 Form 4/A - Amendment Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Christopher Chipman, attorney-in-fact
Stock symbol
VRPX
Transactions as of
Jan 31, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
2/25/2022, 03:44 PM
Date Of Original Report
Feb 2, 2022
Previous filing
Nov 22, 2021
Next filing
May 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +60.7K $0.00 60.7K Jan 31, 2022 Common Stock 60.7K $2.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in three equal annual installments commencing on January 31, 2023.